Merck & Co., Inc. (NYSE: MRK) is recognized as one of the 13 Best Consistent Dividend Stocks to Buy Now, showcasing resilience in healthcare. The company faces challenges with expiring patents and revenue reliance on cancer drug Keytruda, but strong R&D and strategic acquisitions support long-term growth and rising dividends.

In Q2 2025, Merck & Co., Inc. (NYSE: MRK) announced the acquisition of Verona Pharma to enhance its portfolio and pipeline. The company’s optimization program aims to shift resources towards growth areas and drive innovation-led expansion. With consistent dividend growth for 16 years, MRK offers a quarterly dividend of $0.81 per share and a yield of 3.88%.

While Merck (MRK) presents investment potential, some AI stocks may offer greater upside potential with less downside risk. Investors seeking undervalued AI stocks can explore opportunities in the market. For more insights on AI stocks and investment strategies, consult our free report on the best short-term AI stock.

Read more at Yahoo Finance: How Merck (MRK) Maintains Consistent Dividends Through Market Uncertainty